185 related articles for article (PubMed ID: 17356170)
1. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
Madauss KP; Grygielko ET; Deng SJ; Sulpizio AC; Stanley TB; Wu C; Short SA; Thompson SK; Stewart EL; Laping NJ; Williams SP; Bray JD
Mol Endocrinol; 2007 May; 21(5):1066-81. PubMed ID: 17356170
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
3. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Chen W; Ohara N; Wang J; Xu Q; Liu J; Morikawa A; Sasaki H; Yoshida S; Demanno DA; Chwalisz K; Maruo T
J Clin Endocrinol Metab; 2006 Apr; 91(4):1296-304. PubMed ID: 16464945
[TBL] [Abstract][Full Text] [Related]
4. Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system.
Afhüppe W; Sommer A; Müller J; Schwede W; Fuhrmann U; Möller C
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):105-15. PubMed ID: 19130882
[TBL] [Abstract][Full Text] [Related]
5. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
[TBL] [Abstract][Full Text] [Related]
6. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
7. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
[TBL] [Abstract][Full Text] [Related]
8. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T
J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846
[TBL] [Abstract][Full Text] [Related]
9. Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy.
DeManno D; Elger W; Garg R; Lee R; Schneider B; Hess-Stumpp H; Schubert G; Chwalisz K
Steroids; 2003 Nov; 68(10-13):1019-32. PubMed ID: 14667995
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata.
Chwalisz K; DeManno D; Garg R; Larsen L; Mattia-Goldberg C; Stickler T
Semin Reprod Med; 2004 May; 22(2):113-9. PubMed ID: 15164306
[TBL] [Abstract][Full Text] [Related]
11. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
[TBL] [Abstract][Full Text] [Related]
12. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
Wilkens J; Chwalisz K; Han C; Walker J; Cameron IT; Ingamells S; Lawrence AC; Lumsden MA; Hapangama D; Williams AR; Critchley HO
J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
[TBL] [Abstract][Full Text] [Related]
13. Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Nakabayashi K; DeManno D; Chwalisz K; Yoshida S; Maruo T
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1002-11. PubMed ID: 17652152
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
15. Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs).
Chwalisz K; Garg R; Brenner R; Slayden O; Winkel C; Elger W
Reprod Biol Endocrinol; 2006; 4 Suppl 1(Suppl 1):S8. PubMed ID: 17118172
[TBL] [Abstract][Full Text] [Related]
16. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Liu Z; Auboeuf D; Wong J; Chen JD; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7940-4. PubMed ID: 12048256
[TBL] [Abstract][Full Text] [Related]
17. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T
Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
[TBL] [Abstract][Full Text] [Related]
18. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
19. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
[TBL] [Abstract][Full Text] [Related]
20. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
